Literature DB >> 16130191

Yangxueqingnao particles inhibit rat vascular smooth muscle cell proliferation induced by lysophosphatidic acid.

Wei Cai1, Yi Xu, Jun-Zhu Chen, Shu-Ru Huang, Zhen-Ya Lu, Zhan-Kun Wang.   

Abstract

OBJECTIVE: To observe the effect of Yangxueqingnao particles on rat vascular smooth muscle cell (VSMC) proliferation induced by lysophosphatidic acid (LPA).
METHODS: The amount of (3)H-TdR ((3)H-thymidine) admixed in cultured rat VSMC was measured and mitogen-activated protein kinase (MAPK) activity and lipid peroxidation end product malondialdehyde (MDA) content of the VSMC were assayed.
RESULTS: 1x10(-9), 1x10(-8), 1x10(-7) mol/L LPA in a concentration dependent manner, induced the amount of (3)H-TdR admixed, MAP kinase activity, and MDA content of the cultured rat VSMC to increase. However, 5%, 10%, and 15% Yangxueqingnao serum preincubation resulted in a decrease of 23.0%, 42.0%, and 52.0% (P<0.01) respectively in the amount of (3)H-TdR admixed, a decline in VSMC MAP kinase activity of 13.9% (P<0.05), 29.6% (P<0.01), and 48.9% (P<0.01) respectively, and also, a decrease in MDA content of VSMC of 19.4%, 24.7%, and 43.2% (P<0.01) respectively, in the 1x10(-7) mol/L LPA-treated VSMC.
CONCLUSIONS: LPA activates the proliferation and lipid peroxidation of VSMC in a concentration dependent manner. The LPA-induced VSMC proliferation is related to the activity of MAP kinases, enzymes involved in an intracellular signalling pathway. The results of the present study showed that Yangxueqingnao particles can effectively inhibit LPA-induced VSMC proliferation, MAP kinase activation, and reduce lipid peroxidative lesion.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16130191      PMCID: PMC1389907          DOI: 10.1631/jzus.2005.B0892

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  5 in total

1.  Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids.

Authors:  K Hayashi; M Takahashi; W Nishida; K Yoshida; Y Ohkawa; A Kitabatake; J Aoki; H Arai; K Sobue
Journal:  Circ Res       Date:  2001-08-03       Impact factor: 17.367

2.  Effects of lysophosphatidic acid on proliferation and cytosolic Ca++ of human adult vascular smooth muscle cells in culture.

Authors:  I Gennero; J M Xuereb; M F Simon; J P Girolami; J L Bascands; H Chap; B Boneu; P Sié
Journal:  Thromb Res       Date:  1999-06-01       Impact factor: 3.944

3.  Lysophosphatidic acid and intracellular signalling in vascular smooth muscle cells.

Authors:  S Seewald; A Sachinidis; R Düsing; Y Ko; C Seul; P Epping; H Vetter
Journal:  Atherosclerosis       Date:  1997-04       Impact factor: 5.162

4.  Activation of human monocytic cells by lysophosphatidic acid and sphingosine-1-phosphate.

Authors:  Markus Fueller; De An Wang; Gabor Tigyi; Wolfgang Siess
Journal:  Cell Signal       Date:  2003-04       Impact factor: 4.315

5.  [Involvement of endothelin in the proliferative effect of lysophosphatidic acid on vascular smooth muscle cells in rats].

Authors:  Yongsheng Ren; Chunshui Pan; Qizhuan Wu; Yongzheng Pang; Chaoshu Tang; Yongfen Qi
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2003-10
  5 in total
  1 in total

Review 1.  Safety and Clinical Efficacy of Yangxue Qingnao Granules in the Treatment of Chronic Cerebral Circulation Insufficiency: A Systematic Review and Meta-Analysis.

Authors:  Jianbo Guo; Xingjiang Xiong; Yu Cao; Yukun Ding; Qingyong He
Journal:  Evid Based Complement Alternat Med       Date:  2019-08-14       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.